Miwon Specialty Chemical Co Ltd

Miwon Specialty Chemical Co Ltd maintains a strong liquidity position, with a current ratio of 3.91, indicating that it has nearly four times more current assets than current liabilities. The company also holds significant cash and equivalents, amounting to KRW 116.2 billion, which provides a buffer against short-term obligations. The liquidity risk is assessed as low, supported by the company's robust cash reserves and manageable debt levels.

In terms of profitability, Miwon reports a return on equity (ROE) of 3.87% and a return on assets (ROA) of 3.09%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that the company is generating returns, but not at a level that would be considered exceptional within the industry. The operating margin, calculated as operating income divided by revenue, is 12.9%, which is in line with the industry median for specialty chemical producers.

Miwon's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no material geographic diversification beyond South Korea. This concentration increases the company's exposure to regional economic fluctuations and regulatory changes, which could impact its revenue stability. The company does not report revenue by geographic region, but its operations are primarily based in South Korea.

The company's growth trajectory appears to be modest, with no significant revenue growth reported in the most recent period. The capital expenditure for the period was KRW 8.78 billion, which is relatively low compared to the company's total assets, suggesting a conservative approach to reinvestment. The outlook for the current fiscal year does not indicate a material change in revenue direction, with the company maintaining a stable but not aggressive growth strategy.

The risk assessment for Miwon indicates a low probability of dilution, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.09, which is well below the industry median, indicating a conservative capital structure with minimal reliance on debt financing. The company has not issued any new shares in the recent period, and there are no indications of near-term dilution pressure.

Recent filings and transcripts do not highlight any material events or strategic shifts for Miwon Specialty Chemical Co Ltd. The company has not disclosed any major new projects, partnerships, or regulatory challenges in its latest reports. The absence of significant events suggests a stable but uneventful operational environment for the company.

Net margin of 11.6% significantly exceeds the 4.5% cohort median, demonstrating strong bottom-line efficiency relative to competitors.

Debt-to-equity ratio of 0.09 is well below the 0.23 cohort median, reflecting a conservative and low-leverage capital structure.

Cash conversion ratio of 2.44 surpasses the 1.08 cohort median, highlighting robust ability to turn earnings into cash.

Net income grew 12.3% year-over-year to 61.3 billion KRW, outpacing the 4.5% revenue growth rate.

Four-year net income CAGR of -6.4% indicates a long-term declining trend in profitability despite recent annual growth.

Return on equity of 3.87% falls below the 3.93% cohort median, suggesting subpar capital efficiency compared to peers.

Revenue growth stalled with a 0.0% four-year CAGR, showing a lack of top-line expansion over the long term.